
Cost-effectiveness of omalizumab in adults with severe asthma: Results from the Asthma Policy Model
Keywords: اومالیزوماب; Omalizumab; cost-effectiveness; asthma; anti-IgEAQLQ, Asthma Quality of Life Questionnaire; ED, Emergency department; HRQOL, Health-related quality of life; ICS, Inhaled corticosteroid; QALY, Quality-adjusted life year; QAM, Quality-adjusted month